Cancer Research and Treatment

REVIEW ARTICLE 1970 January 1 Clinical Circulating Tumor DNA Testing for Precision Oncology
Circulating tumor DNA (ctDNA) is the portion of the cell-free DNA in the blood of cancer patients released from tumor cells via apoptosis, necrosis, or active release. From 10 mL of blood, the 4-5 mL of plasma obtained from a cancer patient contains 5-10 ng/mL of ctDNA. The plas...

REVIEW ARTICLE 1970 January 1 Utilizing Plasma Circulating Tumor DNA Sequencing for Precision Medicine in the Management of Solid Cancers
Plasma circulating tumor DNA (ctDNA) sequencing has demonstrated clinical utility for tumor molecular profiling at initial diagnosis or tumor progression in advanced solid cancers and is being rapidly incorporated into the clinical practice guidelines, including non–small cell ...

SPECIAL ARTICLE 1970 January 1 Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2020
Purpose The current study provides national cancer statistics and their secular trends in Korea, including incidence, mortality, survival, and prevalence in 2020. Materials and Methods Incidence, survival, and prevalence rates of cancer were calculated using the Korea National ...

SPECIAL ARTICLE 1970 January 1 Prediction of Cancer Incidence and Mortality in Korea, 2023
Purpose This study aimed to report the projected cancer incidence and mortality for the year 2023 to estimate Korea’s current cancer burden. Materials and Methods Cancer incidence data from 1999 to 2020 were obtained from the Korea National Cancer Incidence Database, and cance...

Current Issue

Volume 55(2); Apr 2023

Volume 55(1); January 2023

Volume 54(4); October 2022

Most-read are based on citations from 2021 ~ 2023.

Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2018 ( 14107 times )

Seri Hong, Young-Joo Won, Jae Jun Lee, Kyu-Won Jung, Hyun-Joo Kong, Jeong-Soo Im, Hong Gwan Seo, The Community of Population-Based Regional Cancer Registries

Cancer Res Treat. 2021;53(2):301-315. Published online March 17, 2021 DOI: https://doi.org/10.4143/crt.2021.291

Cited By 172

Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2019 ( 11099 times )

Mee Joo Kang, Young-Joo Won, Jae Jun Lee, Kyu-Won Jung, Hye-Jin Kim, Hyun-Joo Kong, Jeong-Soo Im, Hong Gwan Seo, The Community of Population-Based Regional Cancer Registries

Cancer Res Treat. 2022;54(2):330-344. Published online March 16, 2022 DOI: https://doi.org/10.4143/crt.2022.128

Cited By 71

Prediction of Cancer Incidence and Mortality in Korea, 2021 ( 9561 times )

Kyu-Won Jung, Young-Joo Won, Seri Hong, Hyun-Joo Kong, Jeong-Soo Im, Hong Gwan Seo

Cancer Res Treat. 2021;53(2):316-322. Published online March 17, 2021 DOI: https://doi.org/10.4143/crt.2021.290

Cited By 47

Basic

TM4SF4 and LRRK2 Are Potential Therapeutic Targets in Lung and Breast Cancers through Outlier Analysis ( 7978 times )

Kyungsoo Jung, Joon-Seok Choi, Beom-Mo Koo, Yu Jin Kim, Ji-Young Song, Minjung Sung, Eun Sol Chang, Ka-Won Noh, Sungbin An, Mi-Sook Lee, Kyoung Song, Hannah Lee, Ryong Nam Kim, Young Kee Shin, Doo-Yi Oh, Yoon-La Choi

Cancer Res Treat. 2021;53(1):9-24. Published online September 16, 2020 DOI: https://doi.org/10.4143/crt.2020.434

Cited By 6

Immunotherapy

The Pattern of Time to Onset and Resolution of Immune-Related Adverse Events Caused by Immune Checkpoint Inhibitors in Cancer: A Pooled Analysis of 23 Clinical Trials and 8,436 Patients ( 7674 times )

Si-Qi Tang, Ling-Long Tang, Yan-Ping Mao, Wen-Fei Li, Lei Chen, Yuan Zhang, Ying Guo, Qing Liu, Ying Sun, Cheng Xu, Jun Ma

Cancer Res Treat. 2021;53(2):339-354. Published online November 6, 2020 DOI: https://doi.org/10.4143/crt.2020.790

Cited By 38

Prediction of Cancer Incidence and Mortality in Korea, 2022 ( 7535 times )

Kyu-Won Jung, Young-Joo Won, Mee Joo Kang, Hyun-Joo Kong, Jeong-Soo Im, Hong Gwan Seo

Cancer Res Treat. 2022;54(2):345-351. Published online March 21, 2022 DOI: https://doi.org/10.4143/crt.2022.179

Cited By 15

Practical Advice for South Korean Medical Researchers Regarding Open-Access and Predatory Journals ( 7379 times )

Chai Hong Rim

Cancer Res Treat. 2021;53(1):1-8. Published online September 21, 2020 DOI: https://doi.org/10.4143/crt.2020.816

Cited By 1

Breast Cancer

Combination of Simvastatin and FAC Improves Response to Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer ( 7340 times )

Erwin Danil Yulian, Nurjati Chairani Siregar, Bajuadji

Cancer Res Treat. 2021;53(4):1072-1083. Published online March 9, 2021 DOI: https://doi.org/10.4143/crt.2020.1024

Cited By 10

Systemic Treatment of Advanced Gastroenteropancreatic Neuroendocrine Tumors in Korea: Literature Review and Expert Opinion ( 6911 times )

Changhoon Yoo, Chung Ryul Oh, Seung-Tae Kim, Woo Kyun Bae, Hye-Jin Choi, Do-Youn Oh, Myung-Ah Lee, Baek-Yeol Ryoo

Cancer Res Treat. 2021;53(2):291-300. Published online December 29, 2020 DOI: https://doi.org/10.4143/crt.2020.1233

Cited By 5

Gastrointestinal cancer

Clinical Application of Targeted Deep Sequencing in Metastatic Colorectal Cancer Patients: Actionable Genomic Alteration in K-MASTER Project ( 6902 times )

Youngwoo Lee, Soohyeon Lee, Jae Sook Sung, Hee-Joon Chung, Ah-reum Lim, Ju Won Kim, Yoon Ji Choi, Kyong Hwa Park, Yeul Hong Kim

Cancer Res Treat. 2021;53(1):123-130. Published online August 18, 2020 DOI: https://doi.org/10.4143/crt.2020.559

Cited By 9